• Register
  • Login

European Journal of Molecular & Clinical Medicine

  • Home
  • Browse
    • Current Issue
    • By Issue
    • By Subject
    • Keyword Index
    • Author Index
    • Indexing Databases XML
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Indexing and Abstracting
    • Peer Review Process
    • News
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
Advanced Search

Notice

As part of Open Journals’ initiatives, we create website for scholarly open access journals. If you are responsible for this journal and would like to know more about how to use the editorial system, please visit our website at https://ejournalplus.com or
send us an email to info@ejournalplus.com

We will contact you soon

  1. Home
  2. Volume 9, Issue 8
  3. Author

Online ISSN: 2515-8260

Volume9, Issue8

Safety and efficacy of aloe vera in the treatment of type 2 diabetes mellitus: A randomized control study

    Mohammed Shoaib, Dr. Manjula Bhargava, Dr. Ganpat Devpura, .Dr. Shamsa Fiaz

European Journal of Molecular & Clinical Medicine, 2022, Volume 9, Issue 8, Pages 3174-3181

  • Show Article
  • Download
  • Cite
  • Statistics
  • Share

Abstract

Diabetes mellitus has been described as the most common endocrine disorder that impairs glucose homeostasis resulting in severe complications. Chronic hyperglycemia in diabetic patients is associated with long term damage, dysfunction and eventually the failure of organs, especially the eyes, kidneys, nerves, heart and blood vessels.
Currently, there is a renewed interest in the plant based medicines. One such herbal drug, Aloe Vera used for different clinical purposes claimed for its effect on blood glucose levels.
Total of 240 type 2 diabetes mellitus patients were enrolled and allocated to four groups viz. A, B, C and D. Group A and C will be given conventional anti-diabetic agents, however Group B and D in addition to anti-diabetic agent, Aloe Vera will be given as add on therapy.
While assessing the results and comparing the overall degree of glycaemia control between group A & B, a significant (p<0.004) difference with mean fasting and mean PP blood glucose (p<0.001) were observed. Similarly comparing the overall degree of glycaemia control between group C & D, a significant (p<0.004) difference with mean fasting and mean PP blood glucose (p<0.000) were observed. A significant difference between mean HbA1c recorded before and after the treatment in the groups were treated with Aloe Vera as add on therapy with conventional antidiabetic drugs.
The study concluded that the subjects who were treated with Aloe Vera as an add on therapy with conventional antidiabetic drugs has comparatively produced better clinical outcome in terms of glycaemia control and lower incidence of complications.
Keywords:
    diabetes mellitus FBG PPG HbA1c Aloe Vera
  • PDF (659 K)
  • XML
(2023). Safety and efficacy of aloe vera in the treatment of type 2 diabetes mellitus: A randomized control study. European Journal of Molecular & Clinical Medicine, 9(8), 3174-3181.
Mohammed Shoaib, Dr. Manjula Bhargava, Dr. Ganpat Devpura, .Dr. Shamsa Fiaz. "Safety and efficacy of aloe vera in the treatment of type 2 diabetes mellitus: A randomized control study". European Journal of Molecular & Clinical Medicine, 9, 8, 2023, 3174-3181.
(2023). 'Safety and efficacy of aloe vera in the treatment of type 2 diabetes mellitus: A randomized control study', European Journal of Molecular & Clinical Medicine, 9(8), pp. 3174-3181.
Safety and efficacy of aloe vera in the treatment of type 2 diabetes mellitus: A randomized control study. European Journal of Molecular & Clinical Medicine, 2023; 9(8): 3174-3181.
  • RIS
  • EndNote
  • BibTeX
  • APA
  • MLA
  • Harvard
  • Vancouver
  • Article View: 15
  • PDF Download: 48
  • LinkedIn
  • Twitter
  • Facebook
  • Google
  • Telegram
Journal Information

Publisher:

Email:  editor.ejmcm21@gmail.com

  • Home
  • Glossary
  • News
  • Aims and Scope
  • Privacy Policy
  • Sitemap

 

For Special Issue Proposal : editor.ejmcm21@gmail.com

This journal is licensed under a Creative Commons Attribution 4.0 International (CC-BY 4.0)

Powered by eJournalPlus